Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope

摘要

There is disclosed a combined preparation comprising a glycosylation modulator and a membrane fusion inhibitor for combined, simultaneous or sequential use in the treatment of infections caused by viruses bearing glycosylated envelope proteins.